Investigational Site Number 8002

Lviv 79044

0 studies enrolling now · 3 studies all time

What they study most

Hemophilia, Hemophilia A, Hemophilia B

Studies at this site

• A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis — Completed
• A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors — Completed
• A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors — Completed